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ABST RACT
Giant pancreatic pseudocysts are considered those cysts whose
dimensions exceed 10 cm and are sporadically reported in the literature.
Although there are multiple treatment modalities, there are currently no
treatment guidelines or consensus on the best therapeutic approach for
giant pancreatic pseudocysts. We report the case of a 32-year-old male
patient with a giant pancreatic pseudocyst after an episode of acute
pancreatitis, which was treated by internal surgical drainage through
cyst-jejunal anastomosis. This surgical procedure was followed by the
formation of a retroperitoneal abscess which was resolved by ultrasoundguided drainage. The subsequent evolution of the patient was favorable,
without other complications. Given their complex anatomical relations, the
treatment of giant pseudocysts requires strategies adapted to the local
conditions. The optimal choice of the operative time and of the therapeutic
strategy is based on clinical considerations and the effectiveness of the
method used can be assessed by a long-term follow-up.
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Introduction

Case Presentation

The pancreatic pseudocyst is a fluid peripancreatic
collection padded by a wall consisting of fibrous and
granulation tissue with no epithelial lining, resulting from
the disruption of the pancreatic ducts. Most often, these
ductal disruptions occur after an inflammatory process of
the pancreas or after trauma. Communication with the
pancreatic ducts may be persistent or may be interrupted
by local inflammatory processes [1,2].
Pseudocysts over 10 cm in diameter are considered
"giants" and are rarely reported. Their approach requires
adapted strategies given their complex anatomical relations
[3-5].
There is currently no classification nor guidelines for
the treatment of pancreatic pseudocysts that allow the
optimal choice of the operative time and of the therapeutic
strategy, so that their management is based on clinical
considerations and the experience of the surgeons [6-8].

A 32-year-old male with a history of heavy alcohol use
is hospitalized for pain in the left hypochondrium and left
abdominal flank, nausea and vomiting. These symptoms
occurred at an interval of 8 weeks after an episode of acute
pancreatitis and worsened progressively.
The physical examination reveals tenderness on
palpation and a bulky tumor in the left upper abdominal
quadrant. The patient had no fever and the results of the
laboratory tests were within normal limits.
The abdominal ultrasound reveals a large homogeneous
cystic lesion in the left hypochondrium, well delimited,
with thin walls located anteriorly to the body and tail of the
pancreas, and a polyp in the infundibular region of the
gallbladder, measuring 1.07 cm (Figures 1-2).
A contrast enhanced CT scan of the abdomen showed a
bulky cystic formation at the level of the body and the tail
of the pancreas, with homogeneous fluid content that
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extends caudally to the flank and left iliac fossa, measuring
60/120/ 220mm (Figure 3).

the pseudocyst content through internal drainage by a Rouxen-Y cyst-jejunal anastomosis, cholecystectomy is also
performed (Figure 4).

Figure 1. The ultrasound appearance of the pseudocyst

Figure 4. Cyst-jejunal anastomosis

Figure 2. The ultrasound image of the gallbladder polyp

The histopathological examination of the gallbladder
indicated hypertrophic mucosa and foci of adenomyosis.
The fragment withdrawn intraoperatively from the
pseudocyst wall was described histopathologically as
diffuse fibrosis, vascular congestion and mixed
inflammatory infiltrate.
The postoperative evolution was favorable, with
uneventful discharge on the 7th postoperative day, the
patient being subsequently followed up in the outpatient
department. After 21 days postoperatively, the patient is
hospitalized for fever of 38.5ºC, pain in the left abdominal
flank and altered general condition. The physical
examination reveals pain in the left iliac fossa, where a
tumor formation is perceived upon deep palpation.
The laboratory test results reveal leukocytosis levels of
21,300/ µl and a C-reactive protein level of 293 mg/ l. The
abdominal ultrasound reveals a non-homogeneous
collection of (14.5/3 cm), located anteriorly to the left
psoas muscle (Figure 5).

Figure 3. A CT scan showing a large pancreatic
pseudocyst in the lesser sac extended inferiorly to the
left iliac fossa
Surgery is decided upon and the pancreatic pseudocyst is
opened at the level of the tail of the pancreas, crossing an
avascular area of the transverse mesocolon. After emptying
194

Figure 5. The ultrasound image of the retroperitoneal
abscess
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The CT examination shows a large collection located
anteriorly to the left psoas muscle, with a nonhomogeneous appearance containing gas (Figure 6).

The patient is discharged on the 5th postoperative day,
without fever, with laboratory tests within normal limits.
Subsequently, he is followed up and evaluated in the
outpatient department. Repeated evaluations confirm the
favorable evolution until up to 3 months postoperatively.

Discussion
Epidemiology

Figure 6. The CT image of the retroperitoneal abscess
Under ultrasound guidance, a 12 Fr tube is inserted into
the cavity of the collection and the fetid pus is evacuated.
The tube is maintained until the drainage becomes serous,
and the ultrasound check confirms the disappearance of the
retroperitoneal collection (Figures 7-8).

The etiology of pancreatic pseudocyst is closely related
to the causes which produce the disruption of the
pancreatic ducts. The causes that lead to the formation of
pseudocysts are chronic and acute pancreatitis or
pancreatic trauma. Almost 70% of the pancreatic
pseudocysts are associated with alcohol consumption and
pancreatitis induced by it [1-3].
Alcohol abuse is the leading cause of acute and
chronic pancreatitis, hence the different incidences of
pancreatic pseudocysts reported worldwide. Pseudocysts
associated with alcohol-induced pancreatitis amount to
70% in the USA and South Africa, while in France they
represent 94% of the cases. Chronic pancreatitis as a result
of alcoholism complicated with pseudocysts amount to
71% in the UK and 85% in Finland [4-6].
Gallstones-induced pancreatitis is the cause of 6% of
the pseudocysts, while closed abdominal trauma or
pancreatic lesions during surgery, such as gastric surgery,
cause about 6% of the pseudocysts [7,8].
Other causes of acute pancreatitis leading to acute
pseudocysts are ERCP and pancreatic cancer [9,10].
Diagnosis

Figure 7. The ultrasound-guided drainage of the abscess

Figure 8. The drainage of the retroperitoneal abscess

• Symptoms
The clinical manifestations of pseudocysts cover a very
wide spectrum. Recent episodes of acute pancreatitis,
closed abdominal trauma, pancreatic surgery, or chronic
ethanol use associated with chronic pancreatitis may be
identified in the patients' histories [11].
Small pseudocysts are usually asymptomatic.
Symptoms are caused by complications associated with
pseudocysts. Abdominal pain is caused by the expansion
of the pseudocyst. Symptoms like vomiting, early satiety
or jaundice could also occur. Gastrointestinal bleeding is
caused by vascular occlusion/ thrombosis or arterial
pseudoaneurysm rupture into the pancreatic duct
(hemosuccus pancreaticus). The infection of the
pseudocyst may cause fever and clinical manifestations of
sepsis [12,13].
• Imaging
The imaging methods are the most effective diagnostic
tools for pancreatic pseudocysts, but in the absence of
documented pancreatitis, a cystic lesion in the pancreas
must be interpreted as a cystic tumor until proven
otherwise [14].
195
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Transabdominal ultrasound is the most accessible and
low-cost imaging investigation available for the diagnosis
of pancreatic pseudocysts. Its sensitivity rates are
influenced by the surgeons’ experience and range between
75% and 90% [15].
Pancreatic pseudocysts occur as a round or oval echoic
structure bounded by a smooth wall. In the presence of
necrotic debris and the occurrence of hemorrhage or infection,
pseudocysts can appear with internal echoes [16,17].
A CT scan has a sensitivity of 90% to 100% in the
diagnosis of a pseudocyst. A rounded, thick-walled fluidfilled mass adjacent to the pancreas in the clinical context
of pancreatitis is highly suggestive for the pseudocyst. The
surrounding anatomy and additional pathologies are
highlighted by CT scans. The main drawback of CT scans
is the difficulty in distinguishing between pseudocysts and
cystic neoplasms [18].
These drawbacks are overcome by using endoscopic
ultrasound which provides high quality images, allowing
the differentiation between cystic neoplasm and pancreatic
pseudocysts. Endoscopic ultrasounds can also be used to
perform fine needle aspiration for the laboratory evaluation
of the cystic fluid and to guide endoscopic drainage
[19,20].
Magnetic resonance imaging (MRI) is a sensitive
diagnostic method for pancreatic pseudocysts, but not
routinely used because CT scans offer all of the diagnostic
information that is required for the treatment. MRI is
superior to CT scans in detecting bleeding and debris
within the fluid collections and in depicting
choledocholithiasis [21].
The evolution of pancreatic pseudocysts
Peripancreatic fluid collections occur after episodes of
acute pancreatitis and may progress to the formation of
pseudocysts or may be resorbed. In more than 60% of the
cases, pancreatic pseudocysts are resorbed spontaneously,
so in the initial stages, the attitude is to observe them
closely. Usually, fluid collections are resorbed within
about 4 weeks, this time limit being the separation between
fluid collections and pancreatic pseudocysts. According to
most authors, the time limit for defining a pseudocyst is 6
weeks, especially when the surgical treatment of the
pseudocyst is considered [22,23].
The treatment is imposed by the appearance of
complications - bleeding, infection, digestive tract
obstruction, and portal hypertension. Spontaneous splenic
rupture and cutaneous fistulation of the pancreatic
pseudocyst are exceptional complications [24].
The classification of pancreatic pseudocysts
Several criteria for classifying pancreatic pseudocysts
have been suggested in time.
In 1961, Sarles suggested a classification of
pseudocysts based on the type of pancreatitis that caused
196

their occurrence. Thus, two categories of pseudocysts are
distinguished. The first category includes those resulting
from the necrosis of the pancreatic parenchyma with the
extravasation of pancreatic juice as a consequence of an
episode of acute pancreatitis. These types of pseudocysts
are called “postnecrotic”. The second category of
pseudocysts are the so-called "by retention" and occur in
chronic pancreatitis as a result of pancreatic juice
extravasation into the peripancreatic tissues caused by
the disruption of the pancreatic ducts behind an obstacle
such as stones, plugs, or strictures. This classification
rules out pseudocysts occurring after acute-to-chronic
pancreatitis [25].
The latter category of pseudocysts is included in the
classification of D’Egidio and Schein, which takes into
account both the type of underling pancreatitis and the
communication of the pseudocyst with the pancreatic
ducts. According to this classification, type I,
"postnecrotic" pseudocysts, appear after an episode of
acute pancreatitis, the anatomy of the ducts being normal.
In rare situations, these pseudocysts have a communication
with the pancreatic ducts. Type II pseudocysts include
those that appear after an episode of acute-to-chronic
pancreatitis and in which there is a communication with the
pancreatic ducts. Type III comprises pseudocysts that
appear in chronic pancreatitis associating a ductal
obstruction and in which communication with the
pancreatic ducts is always present [26].
Nealon and Walser propose a classification that takes
into account the anatomy of the pancreatic ducts and the
communication with the pancreatic pseudocyst based on
endoscopic retrograde cholangiopancreatography. This
classification subdivides pancreatic pseudocysts into 7
types. According to the authors' experience, patients with
no communication between the duct and the cyst and
normal duct anatomy are best suited for percutaneous
drainage, while the other categories benefit from surgical
treatment [27].
Pan et al. propose a classification of pancreatic
pseudocysts that can assist in the selection of the optimal
therapy. Based on a retrospective study on 893 patients, the
authors propose a classification that takes into account the
clinical manifestations, the size and the location of
pseudocysts, in addition to the communication with the
pancreatic ducts. Among the possible therapeutic methods,
endoscopic drainage is recommended by the authors as the
first option when conditions permit that the distance
between the pseudocyst and the gastrointestinal wall be
less than 1 cm. Surgical internal drainage is indicated in
situations when the endoscopic treatment is not applicable,
having a success rate of up to 99%. Distal pancreatectomy
is recommended in patients with pseudocysts located in the
pancreatic tail and when splenic vein involvement or upper
gastrointestinal bleeding also occur. The high rate of
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complications (30.8%) and a frequent need for open
surgery (38.5%) is reported in this study for the
percutaneous drainage of the pseudocysts. The authors
recommend this procedure for ruptured cysts and
symptomatic or infected mature cysts in patients who are
not eligible for the surgical treatment [28].
Treatment methods
• Percutaneous drainage under imaging guidance
It is a simple, inexpensive and low trauma intervention
that can be used even when the pseudocyst wall is not
matured. The route of drainage can be retroperitoneal or
transperitoneal, i.e. transgastric or transduodenal. Drainage
guidance
can
be
performed
fluoroscopically,
ultrasonographically or, most commonly, upon computed
tomography. The choice of patients who can benefit from
this procedure must be made based on certain criteria in
order to avoid failure or complications. The best results are
obtained in cases of infected pseudocysts, expanding
immature cysts larger than 5 cm and in patients who are not
eligible for the surgical treatment. Continuous
percutaneous drainage is more effective than simple
percutaneous aspiration [29-31].
This method is not an option for retention pseudocysts
in chronic pancreatitis, where due to communication with
the pancreatic ducts, percutaneous drainage is inefficient.
The complications associated with this type of drainage
are infection, bleeding, pancreatic fistula, and often the
drainage tube blockage due to necrotic tissue [32].
• Endoscopic drainage
Endoscopic transmural drainage is a feasible option
when the pseudocyst is in apposition with the gastric or
duodenal wall. Luminal compression can be obvious on
upper endoscopy and in order to avoid of any intervening
vessels and to ascertain the proximity of the cystic wall, an
endoscopic ultrasound guided puncture of the pseudocyst
is performed. Transmural stents are left in place pending
the complete resolution of the pancreatic pseudocyst,
which is monitored by imaging investigations at 4-week
intervals [33].
Recently, a new device has emerged, which, unlike the
double-pigtail stents (DPS), has a minimal risk of
migration and allows a wider communication between the
pseudocyst and the digestive lumen. This lumen-apposing
metal stent (LAMS) has a biflanged shape that allows for
tissue apposition, but it is associated with a higher bleeding
rate when compared to the DPS [34,35].
Endoscopic transpapillary drainage can be considered
if the pseudocyst is not located in the tail of the pancreas
and communicates with the pancreatic duct [36].
After the pancreatic duct sphincterotomy, a plastic stent
of 5–7Fr is placed into the pseudocyst cavity. These stents
are exchanged every 6–8 weeks until the pseudocyst
regression is obtained [37].

Teoh et al. conclude that endoscopic cyst-gastrostomy
provides overall success for selected patients, but has a
lower primary success rate compared to laparoscopic and
open pancreatic cyst-gastrostomy [38].
According to some authors, the endoscopic treatment
can be considered the first-line treatment approach in
pancreatic pseudocysts, being a procedure that can be
repeated and having a shorter length of hospital stay and
lower hospital cost compared to the surgical group [39].
• Surgical drainage
In 1898, Werner Körte established a turning point in the
treatment of pancreatic pseudocysts by differentiating
them from other pancreatic cystic lesions as a distinct
pathological entity [40].
The internal surgical drainage of the pancreatic
pseudocyst is the oldest method of treatment used. In 1911,
Louis Ombrédanne performed the first internal drainage of
a pancreatic pseudocyst by means of a cystoduodenostomy
[41].
The first pancreatic cystogastrostomy was performed
by Jedlicka in 1921. Ten years later, Jurasz performed the
same posterior gastric wall anastomosis with the
pseudocyst through an anterior gastrotomy. The latter
procedure has the advantage of avoiding dissection through
inflamed tissues and would become the most commonly
used surgical method for pseudocysts in contact with the
posterior wall of the stomach [42,43].
In 1946, Köning first performed the anastomosis of a
pseudocyst with a Roux-en-Y loop. This technical option
is to be chosen in pseudocysts that are not close to the
stomach [44].
Ye Jun et al. published a clinical study on 208 patients
who underwent cystogastrostomy and Roux-en-Y-type
cystojejunostomy in the treatment of pancreatic
pseudocysts, analyzing the risk factors for recurrence and
complications. The results show that there are no
significant differences between the two internal drainage
procedures in terms of cure rate, reoperation rate, and
mortality at approximately 43 months after the procedure,
although theoretically, there is a slightly increased risk of
related
complications
for
Roux-en-Y-type
cystojejunostomy. The average size of pseudocysts in their
study was 10.1-10.7 ± 42.0 cm. Regarding the criteria for
choosing the drainage procedure, the choice was made
intraoperatively by an experienced surgeon with long-term
experience in pancreatic surgery [45].
Internal drainage has the best results for symptomatic
pseudocysts in terms of permanent resolution 91-97%,
with mortality rates of 0-13% and morbidity rates of 1030% [46].
According to Melman, the open approach drainage
method has the highest overall success rate, defined as cyst
resolution, of over 90%, compared to endoscopic or
laparoscopic internal drainage [47].
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Complications related to internal drainage are
secondary hemorrhage, infection, recurrence, amounting to
16% morbidity and 2.5% mortality rates [48].
Over the last two decades, laparoscopic internal
drainage, following the principles of the techniques
described for open surgery, has become a feasible
technique with promising results [49].
Pancreatic resections for pseudocyst have indications in
rarer circumstances, such as biliary or duodenal
obstruction, multiple cysts or gastrointestinal hemorrhage
[50].
Regarding the size of the pseudocyst, cases of giant
pseudocysts are sporadically reported in the literature, and
the results obtained by different treatment methods are
often contradictory. In a series of fifty-two patients with
pancreatic pseudocysts of various sizes, Johnson observed
that the postoperative complication rate was directly
proportional with the size of the pseudocyst. In this series,
four of the pseudocysts were over 15 cm and were treated
by cystogastrostomy and, out of these, three had lifethreatening postoperative complications. The authors
attribute these complications to the incomplete emptying
of the cyst and conclude that cystogastrostomy may not be
appropriate for the treatment of giant pancreatic
pseudocysts [51].
Wang et al. report the case of a 65-year-old man
presenting a pancreatic pseudocyst, measuring 25.7
cm×15.3 cm×10.9 cm, which was drained through an open
cystogastrostomy with uneventful postoperative course
[52].
A good postoperative outcome is reported by Golash
after a cystogastrostomy for a giant pseudocyst of the
pancreas was performed laparoscopically [53].
In a series of ten patients with giant pseudocysts after
acute pancreatitis, Oria et al. first performed a videoassisted pancreatic necrosectomy and then used the
opening in the pseudocyst wall to perform an anastomosis
with a Roux-en-Y limb of jejunum. The authors consider
that by doing so, postoperative retroperitoneal
complications are avoided [54].
Udeshika et al. report the case of a 27-year-old male
presenting a 30-cm pancreatic pseudocyst successfully
treated by means of endoscopic ultrasound (EUS) guided
drainage using stents and pigtails. The authors recommend
this approach as a possible initial method in the
management of giant pseudocysts and follow up with
repeated endoscopy and indicating surgery in case of
failure of this procedure [55].

Conclusions
Cases of giant pancreatic pseudocysts are rarely
reported in the literature. Currently, there is no consensus
on the choice of the optimal treatment method or guidelines
and no studies to assess the associated risk factors,
198

recurrence rate or complications associated with the
treatment of giant pseudocysts compared to small
pseudocysts.
Although there are multiple methods of treatment, it is
difficult to choose the most appropriate one, given the large
size and complex anatomical relations of giant
pseudocysts. Most often, the treatment of choice is made
based on the experience of the surgeon and the technical
equipment available in the hospital and the therapeutic
approach type will be adapted to the conditions. The
effectiveness of the method used can be assessed by a longterm follow-up.
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